辉瑞中国李进晖:本土合作将继续 要向更早的研发阶段延伸

每日经济新闻
Nov 11

11月5日至10日,第八届中国国际进口博览会(以下简称进博会)在上海举行。辉瑞第七次参展,展示了包括在研的膀胱癌免疫抑制剂Sasanlimab、晚期前列腺癌EZH2抑制剂Mevrometostat等在内的肿瘤药物创新研发成果,还重点展出了血友病治疗领域的非因子创新疗法——马塔西单抗。  与以往相比,辉瑞这次露面有两大不同:一方面,这是公司在全球提出“OUTDO CANCER/攻克癌症”“辉瑞中国...

Source Link

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Most Discussed

  1. 1
     
     
     
     
  2. 2
     
     
     
     
  3. 3
     
     
     
     
  4. 4
     
     
     
     
  5. 5
     
     
     
     
  6. 6
     
     
     
     
  7. 7
     
     
     
     
  8. 8
     
     
     
     
  9. 9
     
     
     
     
  10. 10